DS
FLXN

David Shaw’s Flexion Therapeutics, Inc. FLXN Stock Holding History

David Shaw’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,078
Closed -$91K – 5541
2021
Q2 		$91K Sell
11,078
-52,563
-83% -$447K ﹤0.01% 4565
2021
Q1 		$570K Sell
63,641
-14,773
-19% -$169K ﹤0.01% 3448
2020
Q4 		$905K Sell
78,414
-158,596
-67% -$1.84M ﹤0.01% 3080
2020
Q3 		$2.47M Sell
237,010
-466,669
-66% -$5.72M ﹤0.01% 2242
2020
Q2 		$9.25M Buy
703,679
+250,185
+55% +$2.59M 0.01% 1231
2020
Q1 		$3.57M Buy
453,494
+132,787
+41% +$2M 0.01% 1726
2019
Q4 		$6.64M Sell
320,707
-300,236
-48% -$5.06M 0.01% 1508
2019
Q3 		$8.51M Buy
620,943
+75,886
+14% +$900K 0.01% 1269
2019
Q2 		$6.7M Buy
545,057
+90,204
+20% +$1.04M 0.01% 1385
2019
Q1 		$5.68M Buy
454,853
+204,451
+82% +$2.73M 0.01% 1465
2018
Q4 		$2.83M Buy
250,402
+209,809
+517% +$3.29M ﹤0.01% 1884
2018
Q3 		$759K Sell
40,593
-25,906
-39% -$595K ﹤0.01% 2859
2018
Q2 		$1.72M Buy
+66,499
New +$1.73M ﹤0.01% 2353
2017
Q4 		– Sell
-105,458
Closed -$2.55M – 3806
2017
Q3 		$2.55M Buy
105,458
+69,401
+192% +$1.63M ﹤0.01% 1852
2017
Q2 		$729K Sell
36,057
-19,248
-35% -$401K ﹤0.01% 2608
2017
Q1 		$1.49M Buy
55,305
+33,205
+150% +$678K ﹤0.01% 2037
2016
Q4 		$420K Buy
+22,100
New +$422K ﹤0.01% 2952
2016
Q2 		– Sell
-92,815
Closed -$854K – 3606
2016
Q1 		$854K Buy
92,815
+66,060
+247% +$801K ﹤0.01% 2461
2015
Q4 		$516K Sell
26,755
-24,170
-47% -$420K ﹤0.01% 3074
2015
Q3 		$757K Buy
+50,925
New +$1.19M ﹤0.01% 2795

Other funds holding FLXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David Shaw's FLXN Position: Q3 2021 in Review

David Shaw sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2021, closing a stake of 11,078 shares — an estimated $91K sold.

David Shaw first reported a position in FLXN in Q3 2015 and held it in 20 quarters. The position peaked at $9.25M in Q2 2020. 145 funds tracked by Wall St. Rank hold FLXN as of Q3 2021.

  • David Shaw reported no remaining Flexion Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
  • David Shaw sold 11,078 Flexion Therapeutics, Inc. shares in Q3 2021, an estimated $91K.
  • David Shaw first reported a position in Flexion Therapeutics, Inc. in Q3 2015 and held it in 20 quarters.
  • David Shaw's Flexion Therapeutics, Inc. position peaked at $9.25M in Q2 2020.
  • 145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2021.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.